Weill Cornell Medicine
Overview
Weill Cornell Medicine is an academic medical institution that operates an innovation ecosystem, Enterprise Innovation, which facilitates the commercialization of biomedical research through technology licensing, startup incubation, and strategic partnerships.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Salute Safety | Mar 2022 | VC Round | Co-investor |
| Vita Innovations | Feb 2020 | Grant | Co-investor |
| Mission-Driven Tech™ Inc. | Apr 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Rohan Ramakrishna
Professor of Neurological Surgery, Director, Brain Metastases Program
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Weill Cornell Medicine based?
Weill Cornell Medicine is headquartered in New York City, New York, United States.
When was Weill Cornell Medicine founded?
Weill Cornell Medicine was founded in 1898.
How many portfolio companies does Weill Cornell Medicine have?
Weill Cornell Medicine has 6 portfolio companies in Caplight's dataset.
What are some companies in Weill Cornell Medicine's portfolio?
Portfolio companies visible on Caplight include Salute Safety, Vita Innovations, Mission-Driven Tech™ Inc..
What was Weill Cornell Medicine's most recent investment shown here?
Weill Cornell Medicine's most recent investment in this portfolio sample was in Mission-Driven Tech™ Inc. in 2023.
What sectors does Weill Cornell Medicine focus on?
Weill Cornell Medicine focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Weill Cornell Medicine focus on?
Stage focus information for Weill Cornell Medicine is not publicly available.